Semaglutide
Semaglutide is a 31-residue GLP-1 receptor agonist analog with a C18 fatty-acid acylation that extends plasma half-life. It is one of the most heavily characterized reference compounds in GLP-1 receptor pharmacology.
The standard single-receptor GLP-1 baseline for comparative incretin research.
What it is
Semaglutide is a synthetic analog of human GLP-1(7-37) with amino-acid substitutions and a C18 diacid linker that confers albumin binding and an extended plasma half-life.
It is widely used as a mono-agonist reference standard in GLP-1 receptor signaling and incretin pharmacology research. For laboratory use only.
Reconstitution & storage
- Reconstitute with bacteriostatic water — add slowly down the vial wall and swirl gently; do not shake.
- Store lyophilized vials at -20°C; once reconstituted keep at 2–8°C and use within ~4 weeks.
- Protect from light and avoid repeated freeze–thaw cycles.
Cited research applications
Questions
Related compounds
For Research Use Only. Not for human or animal consumption. This product has not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure, or prevent any disease. Semaglutide is sold strictly as a research chemical for in-vitro and pre-clinical laboratory investigation only.